๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Parkinson's Disease (PD)
Clinical trial register · China

Parkinson's Disease (PD) Trials in China, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Shanghai 5 Beijing 2 Hefei 2 Jinan 1 Zhejiang 1
Narrow the registerReset
Recruitment status
Phase
Site location
Shanghai5 Beijing2 Hefei2 Jinan1 Zhejiang1
All 16 locations
Target enrolment
to

Parkinson's Disease (PD) trials in China

14 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
ZR001 Chemogenetics Gene Therapy Study in Patients With Parkinson's Disease
NCT07718659Parkinson's Disease (PD), Parkinsonian Disorders
Qianfoshan Hospital
Phase 1
8
Jinan
2026-12-01
Not yet open
Phase โ…ข Clinical Trial to Evaluate the Efficacy and Safety of TJ0113 Capsules in Patients With Early-Onset Parkinson's Disease
NCT07741045Parkinson's Disease (PD), Parkinson Disease 6, Early-Onset
DrugTJ0113
Hangzhou PhecdaMed Co., Ltd.
Phase 3
300
Beijing, Chongqing, Guangzhou, Zhengzhou, Wuhan, Changsha, Suzhou, Shanghai
2026-08-03
Recruiting
STN-tTIS With Different Intervention Intervals Versus Standard Medical Treatment for Parkinson's Disease
NCT07774312Parkinson's Disease (PD)
Ruijin Hospital
Not applicable
60
Shanghai
2026-07-27
Not yet open
Immediate Effects of External Trigeminal Nerve Stimulation on Motor Dysfunction in Parkinson's Disease
NCT07656129Parkinson's Disease (PD)
Zhengli Di
Not applicable
30
Xi'an
2026-06-15
Recruiting
A Study to Evaluate Satety, Tolerability, Biodistribution, Radiation Dosimetry, and Pharmacokinetics of SST001 in Healthy Volunteers, Patients With PD and Patients With MSA
NCT07604116Multiple System Atrophy (MSA), Parkinson's Disease (PD)
Synusight Biotech (Shanghai) Co., Ltd.
Phase 1
30
Wuxi, Shanghai
2026-06-15
Recruiting
Subthalamic Nucleus-Targeted Transcranial Temporal Interference Stimulation for Motor and Non-Motor Symptoms in Parkinson's Disease
NCT07625540Parkinson's Disease (PD)
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Not applicable
32
Shanghai
2026-05-20
Not yet open
Clinical Study of Chemogenetic Gene Therapy With AAV for Parkinson's Disease Using Stereotactic Surgery in the Subthalamic Nucleus
NCT07533591Parkinson's Disease (PD)
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase EARLY_PHASE1
6
Zhejiang
2026-05
By invitation
China-NINE Cohort๏ผšNeuroimmune Network in Elderly / Neurodegeneration
NCT07586501Cognitive Dysfunction, Cognitive Dysfunction, Cognitive Disorder, Parkinson's Disease (PD)
Yantai Yuhuangding Hospital
Observational
260
Yantai
2026-01-16
Recruiting
Non-Invasive Fundus Retinal Detection Technology for Early Diagnosis of Parkinson's Disease
NCT07244640Parkinson's Disease (PD)
Second Affiliated Hospital, Zhejiang University, School of Medicine
Observational
200
Hangzhou
2025-11
Not yet open
Mindfulness-Enhanced Dual-Task Training in PD-MCI
NCT06930742Mild Cognitive Impairment (MCI), Parkinson's Disease (PD)
Nanjing Mingzhou Rehabilitation Hospital
Not applicable
90
Nanjing
2025-05-01
Recruiting
Shanghai Clinical Cohort - Parkinson's Disease (Reserve)
NCT07353463Parkinson's Disease (PD), Multiple System Atrophy
Ruijin Hospital
Observational
700
Shanghai
2025-04-01
Recruiting
Acupuncture and Moxibustion for Motor Symptoms in Early Parkinson's Disease
NCT06874803Parkinson's Disease (PD)
Jiani Wu
Not applicable
60
Beijing
2024-08-01
Rows per page Showing 1–14 of 14
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 27 September 2026. https://priyalifescience.com/clinical-trials-china/condition/parkinson-s-disease-pd

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 14 of those studies listing the condition Parkinson's Disease (PD).

How many Parkinson's Disease (PD) trials are recruiting in China?

6 of the 14 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 7 have not yet opened recruitment, 0 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Parkinson's Disease (PD)), 14 studies
PhaseStudiesRecruitingShare
Not applicable5335.7%
Observational3221.4%
Phase 13121.4%
Phase EARLY_PHASE12014.3%
Phase 3107.1%

Most active sponsors

Lead sponsors with the most studies (Parkinson's Disease (PD))
Lead sponsorStudiesRecruiting
Ruijin Hospital22
Second Affiliated Hospital, Zhejiang University, School of Medicine21
Hangzhou PhecdaMed Co., Ltd.10
iRegene Therapeutics Co., Ltd.10
Jiani Wu11
Lingyi Biotech Co., Ltd.10
Nanjing Mingzhou Rehabilitation Hospital10
Qianfoshan Hospital10
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine11
Synusight Biotech (Shanghai) Co., Ltd.11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.